Correlation Between Visa and BCWORLD PHARM

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and BCWORLD PHARM at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and BCWORLD PHARM into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and BCWORLD PHARM Co, you can compare the effects of market volatilities on Visa and BCWORLD PHARM and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of BCWORLD PHARM. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and BCWORLD PHARM.

Diversification Opportunities for Visa and BCWORLD PHARM

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Visa and BCWORLD is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and BCWORLD PHARM Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BCWORLD PHARM and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with BCWORLD PHARM. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BCWORLD PHARM has no effect on the direction of Visa i.e., Visa and BCWORLD PHARM go up and down completely randomly.

Pair Corralation between Visa and BCWORLD PHARM

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.59 times more return on investment than BCWORLD PHARM. However, Visa Class A is 1.71 times less risky than BCWORLD PHARM. It trades about 0.12 of its potential returns per unit of risk. BCWORLD PHARM Co is currently generating about -0.04 per unit of risk. If you would invest  28,808  in Visa Class A on September 23, 2024 and sell it today you would earn a total of  2,963  from holding Visa Class A or generate 10.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy96.92%
ValuesDaily Returns

Visa Class A  vs.  BCWORLD PHARM Co

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in January 2025.
BCWORLD PHARM 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BCWORLD PHARM Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, BCWORLD PHARM is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Visa and BCWORLD PHARM Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and BCWORLD PHARM

The main advantage of trading using opposite Visa and BCWORLD PHARM positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, BCWORLD PHARM can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BCWORLD PHARM will offset losses from the drop in BCWORLD PHARM's long position.
The idea behind Visa Class A and BCWORLD PHARM Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance